Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor β

Experimental Hematology

Volumn 28, Issue 2, 2000, Pages 128-139

  Wiesmann, Anne ^a   Kim, Mijung ^a   Georgelas, Ann ^a   Searles, A Elena ^b   Cooper, Donna D ^a   Green, Wayne F ^b   Spangrude, Gerald J ^a,b  

^a Department of Oncological Sciences ^*  (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Cell cycle progression; Hematopoietic stem cells

Indexed keywords

STEEL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL CYCLE; CELL SUSPENSION; CLONOGENESIS; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; BLOOD CELL COUNT; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033956511     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00141-1     Document Type: Article

References (70)

1. Hodgson G.S., Bradley T.R., Martin R.F., Sumner M., Fry P. Recovery of proliferating haemopoietic progenitor cells after killing by hydroxyurea. Cell Tissue Kinet. 8:1975;51.
2. Hodgson G.S., Bradley T.R. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment. evidence for a pre-CFU-S cell? Nature. 281:1979;381.
3. Bertoncello I., Bradley T.R., Hodgson G.S. Characterization and enrichment of macrophage progenitor cells from normal and 5-fluorouracil treated mouse bone marrow by unit gravity sedimentation. Exp Hematol. 9:1981;604.
4. Fleming W.H., Alpern E.J., Uchida N., Ikuta K., Spangrude G.J., Weissman I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 122:1993;897.
5. 1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood. 89:1997;465.
6. Leemhuis T., Yoder M.C., Grigsby S., Aguero B., Eder P., Srour E.F. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. Exp Hematol. 24:1996;1215.
7. 1 phase of the cell cycle. Blood. 90:1997;4384.
8. Spangrude G.J., Johnson G.R. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A. 87:1990;7433.
9. Gothot A., van der Loo J.C., Clapp D.W., Srour E.F. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 92:1998;2641.
10. Roberts A.W., Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood. 86:1995;1600.
11. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood. 89:1997;1189.
12. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood. 87:1996;1644.
13. + cells before and after cytokine stimulation. Blood. 90:1997;194.
14. Peters S.O., Kittler E.L., Ramshaw H.S., Quesenberry P.J. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood. 87:1996;30.
15. + cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood. 83:1994;128.
16. Miller C.L., Eaves C.J. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci U S A. 94:1997;13648.
17. Petzer A.L., Hogge D.E., Landsdorp P.M., Reid D.S., Eaves C.J. Self-renewal of primitive human hematopoietic cells (long-term-culture- initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A. 93:1996;1470.
18. 1 human hematopoietic stem cells. Proc Natl Acad Sci U S A. 95:1998;11939.
19. Case S.S., Price M.A., Jordan C.T., Yu X.J., Wang L., Bauer G., Haas D.L., Xu D., Stripecke R., Naldini L., Kohn D.B., Crooks G.M. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A. 96:1999;2988.
20. Chatterjee S., Li W., Wong C.A., Fisher-Adams G., Lu D., Guha M., Macer J.A., Forman S.J., Wong K.K. Jr. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood. 93:1999;1882.
21. Williams D.A. Ex vivo expansion of hematopoietic stem and progenitor cells. Robbing Peter to pay Paul? Blood. 81:1993;3169.
22. Lemischka I.R. What we have learned from retroviral marking of hematopoietic stem cells. Curr Topics Micro Immunol. 177:1992;59.
23. Jordan C.T., Lemischka I.R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4:1990;220.
24. Drize N., Chertkov J., Sadovnikova E., Tiessen S., Zander A. Long-term maintenance of hematopoiesis in irradiated mice by retrovirally transduced peripheral blood stem cells. Blood. 89:1997;1811.
25. Kittler E.L., Peters S.O., Crittenden R.B., Debatis M.E., Ramshaw H.S., Stewart F.M., Quesenberry P.J. Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood. 90:1997;865.
26. Ramshaw H.S., Rao S.S., Crittenden R.B., Peters S.O., Weier H.U., Quesenberry P.J. Engraftment of bone marrow cells into normal unprepared hosts. effects of 5-fluorouracil and cell cycle status Blood. 86:1995;924.
27. + cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow J Exp Med. 175:1992;175.
28. Spangrude G.J., Brooks D.M. Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset. Blood. 80:1992;1957.
29. Nibley W.E., Spangrude G.J. Primitive stem cells alone mediate rapid marrow recovery and mulitlineage engraftment after transplantation. Bone Marrow Transplant. 21:1998;345.
30. Spangrude G.J., Brooks D.M., Tumas D.B. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells. in vivo expansion of stem cell phenotype but not function Blood. 85:1995;1006.
31. + hemopoietic stem cells. J Exp Med. 175:1992;1443.
32. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science. 241:1988;58.
33. Randall T.D., Weissman I.L. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells. resting stem cells or mystery population? Stem Cells. 16:1998;38.
34. Shen F.-W. Monoclonal antibodies to mouse lymphocyte differentiation alloantigens. Hämmerling G.J., Hämmerling U., Kearney J.F. Monoclonal antibodies and T-cell hybridomas. 1981;Elsevier/North Holland Biomedical Press, Amsterdam. 25p.
35. Spangrude G.J., Scollay R. Differentiation of hematopoietic stem cells in irradiated mouse thymic lobes. Kinetics and phenotype of progeny. J Immunol. 145:1990;3661.
36. Jacobsen S.E., Keller J.R., Ruscetti F.W., Kondaiah P., Roberts A.B., Falk L.A. Bidirectional effects of transforming growth factor beta (TGF-beta) on colony-stimulating factor-induced human myelopoiesis in vitro. differential effects of distinct TGF-beta isoforms Blood. 78:1991;2239.
37. Sasaki H., Matsuda M., Lu Y., Ikuta K., Matsuyama S., Hirabayashi Y., Mitsui H., Matsumura T., Muramatsu M., Tsukada T., Aizawa S., Inoue T. A fraction unresponsive to growth inhibition by TGF-beta among the high- proliferative potential progenitor cells in bone marrow of p53- deficient mice. Leukemia. 11:1997;239.
38. low cells in which anti-TGF-beta upmodulates c-kit. Blood. 86:1995;1729.
39. Jacobsen S.E., Ruscetti F.W., Dubois C.M., Lee J., Boone T.C., Keller J.R. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood. 77:1991;1706.
40. + hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. Exp Hematol. 22:1994;985.
41. van Bekkum D.W., van Noord M.J., Maat B., Dicke K.A. Attempts at identification of hemopoietic stem cell in mouse. Blood. 38:1971;547.
42. Zijlmans J.M., Visser J.W., Laterveer L., Kleiverda K., Heemskerk D.P., Kluin P.M., Willemze R., Fibbe W.E. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci U S A. 95:1998;725.
43. Papayannopoulou T., Craddock C., Nakamoto B., Priestley G.V., Wolf N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci U S A. 92:1995;9647.
44. Wiesmann A., Spangrude G.J. Marrow engraftment of hematopoietic stem and progenitor cells is independent of Gαi-coupled chemokine receptors. Exp Hematol. 27:1999;946.
45. Muench M.O., Firpo M.T., Moore M.A.S. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood. 81:1993;3463.
46. Szilvassy S.J., Weller K.P., Chen B., Juttner C.A., Tsukamoto A., Hoffman R. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood. 88:1996;3642.
47. Peters S.O., Kittler E.L., Ramshaw H.S., Quesenberry P.J. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol. 23:1995;461.
48. Habibian H.K., Peters S.O., Hsieh C.C., Wuu J., Vergilis K., Grimaldi C.I., Reilly J., Carlson J.E., Frimberger A.E., Stewart F.M., Quesenberry P.J. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med. 188:1998;393.
49. Engel M.E., Datta P.K., Moses H.L. Signal transduction by transforming growth factor-beta. a cooperative paradigm with extensive negative regulation J Cell Biochem. 30-31:1998;111.
50. Genestier L., Kasibhatla S., Brunner T., Green D.R. Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med. 189:1999;231.
51. Schiott A., Sjogren H.O., Lindvall M. The three isoforms of transforming growth factor-beta co-stimulate rat T cells and inhibit lymphocyte apoptosis. Scand J Immunol. 48:1998;371.
52. Dybedal I., Guan F., Borge O.J., Veiby O.P., Ramsfjell V., Nagata S., Jacobsen S.E. Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood. 90:1997;3395.
53. Kuo M.L., Chen C.W., Jee S.H., Chuang S.E., Cheng A.L. Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells. Biochem J. 327:1997;663.
54. 2+ homeostasis and rescues cortical neurons from apoptotic death. J Neurosci Res. 49:1997;600.
55. Cashman J.D., Eaves C.J., Sarris A.H., Eaves A.C. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. Blood. 92:1998;2338.
56. Ohta M., Greenberger J.S., Anklesaria P., Bassols A., Massague J. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature. 329:1987;539.
57. Keller J.R., McNiece I.K., Sill K.T., Ellingsworth L.R., Quesenberry P.J., Sing G.K., Ruscetti F.W. Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood. 75:1990;596.
58. De Bruyn C., Delforge A., Bron D., Ley P., de Hemptinne D., Stryckmans P. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. Stem Cells. 12:1994;616.
59. Heinrich M.C., Dooley D.C., Keeble W.W. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 85:1995;1769.
60. Ohmori T., Yang J.L., Price J.O., Arteaga C.L. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Exp Cell Res. 245:1998;350.
61. Ando K., Griffin J.D. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Oncogene. 10:1995;751.
62. + human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol. 22:1994;903.
63. + hematopoietic progenitors. Blood. 86:1995;4454.
64. Kiem H.P., Andrews R.G., Morris J., Peterson L., Heyward S., Allen J.M., Rasko J.E., Potter J., Miller A.D. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood. 92:1998;1878.
65. Holyoake T.L., Freshney M.G., McNair L., Parker A.N., McKay P.J., Steward W.P., Fitzsimons E., Graham G.J., Pragnell I.B. Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood. 87:1996;4589.
66. Yonemura Y., Ku H., Lyman S.D., Ogawa M. In vitro expansion of hematopoietic progenitors and maintenance of stem cells. comparison between FLT3/FLK-2 ligand and KIT ligand Blood. 89:1997;1915.
67. Berger L.C., Hawley T.S., Lust J.A., Goldman S.J., Hawley R.G. Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. Biochem Biophys Res Commun. 202:1994;596.
68. Neben S., Donaldson D., Fitz L., Calvetti J., Neben T., Turner K., Hirayama F., Ogawa M. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development. Exp Hematol. 24:1996;783.
69. Hirayama F., Lyman S.D., Clark S.C., Ogawa M. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood. 85:1995;1762.
70. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 283:1999;845.